Pulse एक्सप्लोर nav.journalClub बहसें ट्रेंडिंग शोधकर्ता

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

होम एक्सप्लोर nav.journalClub ट्रेंडिंग

⌘+K

Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis | Synapse

February 9, 2015Open Access

Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis

Key Points

Key points are not available for this paper at this time.

Abstract

This pilot study provides preliminary clinical data indicating that TUDCA is safe and may be effective in ALS.

Read Full Paperexternally

AI से पूछें

Like

Bookmark

Share

View Full Paper

AI से पूछें

Like

Bookmark

Share

View Full Paper

Cite This Study

Elia et al. (Mon,) studied this question.

synapsesocial.com/papers/69d78128aa68b335b4f31d2f https://doi.org/https://doi.org/10.1111/ene.12664

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis2000 · 5,417 citations
2Bile acids and apoptosis modulation: an emerging role in experimental Alzheimer's disease2008 · 110 citations
3Tauroursodeoxycholic acid for treatment of primary biliary cirrhosis1996 · 47 citations
4The role of p53 in apoptosis.2010 · 284 citations
5Regulation of Neuronal Cell Death and Neurodegeneration by Members of the Bcl-2 Family: Therapeutic Implications2005 · 104 citations